X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-13 | DVA | Davita Inc. | Rodriguez Javier | CEO | S - Sale | $164.69 | -59,881 | 837,835 | -7% | -$9,861,637 | |||||
2024-09-12 | AGL | Agilon Health, Inc. | Sell Steven | CEO, Pres | P - Purchase | $3.36 | +20,000 | 396,037 | +5% | +$67,188 | ||||||
2024-09-06 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $15.03 | -15,000,000 | 73,822,952 | -17% | -$225,450,000 | ||||||
2024-09-06 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $15.03 | -15,000,000 | 73,822,952 | -17% | -$225,450,000 | ||||||
2024-09-06 | SHC | Sotera Health Co | Gtcr Investment Xi LLC | Dir, 10% | S - Sale | $15.03 | -10,000,000 | 49,215,301 | -17% | -$150,300,000 | ||||||
2024-08-28 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $0.48 | +1,351,351 | 6,049,331 | +29% | +$650,000 | ||||||
| M | 2024-08-27 | DVA | Davita Inc. | Ackerman Joel | CFO, Treasuer | S - Sale | $155.06 | -68,769 | 106,741 | -39% | -$10,663,371 | |||||
| M | 2024-08-26 | DVA | Davita Inc. | Rodriguez Javier | CEO | S - Sale | $155.93 | -40,119 | 897,716 | -4% | -$6,255,892 | |||||
| M | 2024-08-15 | DVA | Davita Inc. | Staffieri Michael David | COO, DKC | S - Sale | $150.13 | -42,119 | 209,365 | -17% | -$6,323,508 | |||||
2024-08-13 | DVA | Davita Inc. | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | S - Sale | $146.21 | -7,857 | 83,011 | -9% | -$1,148,766 | ||||||
2024-07-16 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $30.00 | -9,030 | 362,583 | -2% | -$270,900 | ||||||
2024-06-28 | PGNY | Progyny, Inc. | Scott Cheryl | Dir | S - Sale | $28.39 | -1,462 | 10,098 | -13% | -$41,506 | ||||||
| D | 2024-06-26 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.97 | +20,999 | 8,410,000 | 0% | +$20,314 | |||||
| M | 2024-06-25 | MGRX | Mangoceuticals, Inc. | Hamilton Alex P. | Dir | S - Sale | $0.32 | -125,000 | 50,000 | -71% | -$39,834 | |||||
| DM | 2024-06-20 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.88 | +6,270 | 8,389,001 | 0% | +$5,543 | |||||
| D | 2024-06-06 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.83 | +16,000 | 8,382,731 | 0% | +$13,274 | |||||
| D | 2024-05-31 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.75 | +6,084 | 8,366,731 | 0% | +$4,563 | |||||
| DM | 2024-05-24 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.74 | +8,800 | 8,360,647 | 0% | +$6,512 | |||||
2024-05-28 | MRAI | Marpai, Inc. | Pons Robert M | Dir | P - Purchase | $0.87 | +5,000 | 84,200 | +6% | +$4,372 | ||||||
| M | 2024-05-24 | MRAI | Marpai, Inc. | Johnson Steve Andrew | CFO | P - Purchase | $0.97 | +8,500 | 368,061 | +2% | +$8,275 | |||||
2024-05-29 | MRAI | Marpai, Inc. | Moazami Mohsen | Dir | S - Sale | $0.68 | -15,000 | 35,000 | -30% | -$10,182 | ||||||
| D | 2024-05-21 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.71 | +100 | 8,351,847 | 0% | +$71 | |||||
| D | 2024-05-16 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.71 | +100 | 8,351,747 | 0% | +$71 | |||||
2024-05-16 | MRAI | Marpai, Inc. | Pons Robert M | Dir | P - Purchase | $2.10 | +5,000 | 79,200 | +7% | +$10,500 | ||||||
2024-05-10 | DVA | Davita Inc. | Desoer Barbara J | Dir | S - Sale | $138.81 | -5,030 | 10,954 | -31% | -$698,214 | ||||||
2024-05-14 | VMD | Viemed Healthcare, Inc. | Heltz Sabrina | Dir | P - Purchase | $7.08 | +2,820 | 41,040 | +7% | +$19,977 | ||||||
2024-05-10 | MRAI | Marpai, Inc. | Dendy Michael Charles | Dir | S - Sale | $2.32 | -45,123 | 78,727 | -36% | -$104,766 | ||||||
2024-05-10 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $2.66 | +5,000 | 606,454 | +1% | +$13,300 | ||||||
2024-05-10 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $2.49 | +10,000 | 4,002,980 | 0% | +$24,899 | ||||||
2024-05-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $31.95 | -4,515 | 380,038 | -1% | -$144,254 | ||||||
| DM | 2024-04-08 | BRTX | Biorestorative Therapies, Inc. | Silva Francisco | VP of Research, Development | P - Purchase | $1.23 | +8,308 | 167,895 | +5% | +$10,229 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.52 | -1,000 | 83,631 | -1% | -$37,523 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale+OE | $37.60 | -6,395 | 384,553 | -2% | -$240,452 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $37.62 | -11,165 | 50,119 | -18% | -$419,979 | |||||
| D | 2024-03-27 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.80 | -71,272 | 86,312 | -45% | -$2,694,267 | |||||
| DM | 2024-03-25 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.63 | -2,902 | 86,312 | -3% | -$109,217 | |||||
| D | 2024-03-21 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.74 | -5,826 | 86,312 | -6% | -$219,877 | |||||
2024-03-14 | AGL | Agilon Health, Inc. | Kornitzer Benjamin | Chief Med., Quality Officer | P - Purchase | $0.00 | +5,434 | 62,058 | +10% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Venkatachaliah Girish | CTO | P - Purchase | $0.00 | +5,434 | 39,950 | +16% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | P - Purchase | $0.00 | +274,455 | 258,732 | -1746% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Desai Veeral | Chief Strategy, Dev. Officer | P - Purchase | $0.00 | +11,956 | 306,641 | +4% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Bensley Timothy | CFO | P - Purchase | $0.00 | +14,945 | 43,365 | +53% | +$0 | ||||||
2024-03-07 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.65 | +910,000 | 3,992,980 | +30% | +$1,501,500 | ||||||
2024-03-04 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $14.31 | -16,594,363 | 88,822,952 | -16% | -$237,423,849 | ||||||
2024-03-04 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $14.31 | -16,594,363 | 88,822,952 | -16% | -$237,423,849 | ||||||
2024-03-04 | SHC | Sotera Health Co | Gtcr Investment Xi LLC | Dir, 10% | S - Sale | $14.31 | -11,062,908 | 59,215,301 | -16% | -$158,282,556 | ||||||
2024-03-04 | SHC | Sotera Health Co | Klee Ann R. | Dir | S - Sale | $14.31 | -5,750 | 86,735 | -6% | -$82,268 | ||||||
| D | 2024-03-04 | SHC | Sotera Health Co | Rutz Michael P | Pres of Sterigenics | S - Sale+OE | $14.31 | -83,109 | 544,409 | -13% | -$1,189,082 | |||||
| D | 2024-03-04 | SHC | Sotera Health Co | Petras Michael B. Jr. | COB, CEO | S - Sale+OE | $14.31 | -1,003,870 | 6,153,329 | -14% | -$14,362,870 | |||||
| D | 2024-03-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $36.64 | -12,610 | 37,360 | -25% | -$461,977 | |||||
2024-03-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $36.63 | -11,009 | 140,948 | -7% | -$403,260 | ||||||
| DM | 2024-02-26 | DVA | Davita Inc. | Rodriguez Javier | CEO | S - Sale+OE | $126.18 | -75,000 | 494,480 | -13% | -$9,463,597 | |||||
| D | 2024-02-21 | DVA | Davita Inc. | Staffieri Michael David | COO, DKC | S - Sale+OE | $119.81 | -29,488 | 196,193 | -13% | -$3,533,025 | |||||
| D | 2024-02-21 | DVA | Davita Inc. | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | S - Sale+OE | $120.73 | -11,285 | 81,297 | -12% | -$1,362,438 | |||||
| D | 2024-02-16 | DVA | Davita Inc. | Hearty James O | Chief Compliance Officer | S - Sale+OE | $119.64 | -26,164 | 20,264 | -56% | -$3,130,269 | |||||
| DM | 2024-02-08 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | P - Purchase | $1.29 | +160,000 | 1,316,948 | +14% | +$206,023 | |||||
| DM | 2024-02-07 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | P - Purchase | $1.35 | +120,000 | 765,017 | +19% | +$162,255 | |||||
2024-02-06 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $40.00 | -2,260 | 158,532 | -1% | -$90,400 | ||||||
| D | 2024-02-05 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $38.50 | -20,000 | 86,312 | -19% | -$769,928 | |||||
| D | 2024-02-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $37.84 | -12,651 | 43,871 | -22% | -$478,767 | |||||
2024-02-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $37.89 | -6,395 | 160,792 | -4% | -$242,307 | ||||||
| DM | 2024-02-01 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $38.60 | -60,000 | 86,312 | -41% | -$2,316,126 | |||||
2024-01-16 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $0.92 | +1,100,000 | 3,082,980 | +55% | +$1,012,110 | ||||||
2024-01-16 | MRAI | Marpai, Inc. | Pons Robert M | Dir | P - Purchase | $0.92 | +12,100 | 74,200 | +19% | +$11,133 | ||||||
2024-01-16 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $0.92 | +210,000 | 601,454 | +54% | +$193,221 | ||||||
| D | 2024-01-08 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.88 | -66,002 | 86,312 | -43% | -$2,500,156 | |||||
| D | 2024-01-02 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $36.59 | -12,368 | 46,871 | -21% | -$452,540 | |||||
2024-01-02 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $36.81 | -6,395 | 167,187 | -4% | -$235,400 | ||||||
| D | 2024-01-02 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.58 | -13,998 | 86,312 | -14% | -$526,024 | |||||
| DM | 2023-12-26 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.80 | -156,031 | 88,439 | -64% | -$5,898,285 | |||||
| DM | 2023-12-20 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.87 | -162,906 | 88,439 | -65% | -$6,169,347 | |||||
| D | 2023-12-14 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.53 | -1,063 | 88,439 | -1% | -$39,894 | |||||
2023-12-14 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.97 | +150,000 | 1,982,980 | +8% | +$295,500 | ||||||
2023-12-14 | MRAI | Marpai, Inc. | Pons Robert M | Dir | P - Purchase | $1.81 | +12,100 | 12,100 | New | +$21,901 | ||||||
2023-12-14 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $1.97 | +50,000 | 391,454 | +15% | +$98,500 | ||||||
2023-12-11 | PGNY | Progyny, Inc. | Gordon Kevin K | Dir | S - Sale | $35.93 | -2,500 | 9,854 | -20% | -$89,825 | ||||||
2023-12-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $34.13 | -12,696 | 173,582 | -7% | -$433,314 | ||||||
| D | 2023-12-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $34.62 | -25,087 | 49,983 | -33% | -$868,512 | |||||
| D | 2023-12-01 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | S - Sale+OE | $1.88 | -250 | 645,017 | 0% | -$469 | |||||
| D | 2023-11-27 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | S - Sale+OE | $1.89 | -278 | 645,267 | 0% | -$525 | |||||
2023-11-29 | AGL | Agilon Health, Inc. | Schwaneke Jeffrey A. | Dir | P - Purchase | $11.22 | +22,300 | 31,931 | +232% | +$250,206 | ||||||
2023-11-21 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.19 | +200,000 | 1,832,980 | +12% | +$238,680 | ||||||
2023-11-17 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $1.23 | +100,000 | 341,454 | +41% | +$123,000 | ||||||
| D | 2023-10-02 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.80 | +55,000 | 8,351,647 | +1% | +$44,000 | |||||
| DM | 2023-09-26 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.85 | +25,000 | 8,296,647 | 0% | +$21,250 | |||||
| D | 2023-09-22 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.82 | +400 | 8,271,647 | 0% | +$328 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |